Remote ischemic post-conditioning promotes hematoma resolution via AMPK-dependent immune regulation

Kumar Vaibhav, Molly Braun, Mohammad Badruzzaman Khan, Sumbul Fatima, Nancy Saad, Adarsh Shankar, Zenab T. Khan, Ruth Babette Harris, Qiuhua Yang, Yuqing Huo, Ali Syed Arbab, Shailendra Giri, Cargill Herley Alleyne, John R Vender, David C Hess, Babak Baban, MD Nasrul Hoda, Krishnan Michael Dhandapani

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Spontaneous intracerebral hemorrhage (ICH) produces the highest acute mortality and worst outcomes of all stroke subtypes. Hematoma volume is an independent determinant of ICH patient outcomes, making clot resolution a primary goal of clinical management. Herein, remote-limb ischemic post-conditioning (RIC), the repetitive inflation-deflation of a blood pressure cuff on a limb, accelerated hematoma resolution and improved neurological outcomes after ICH in mice. Parabiosis studies revealed RIC accelerated clot resolution via a humoral-mediated mechanism. Whereas RIC increased anti-inflammatory macrophage activation, myeloid cell depletion eliminated the beneficial effects of RIC after ICH. Myeloid-specific inactivation of the metabolic regulator, AMPKα1, attenuated RIC-induced anti-inflammatory macrophage polarization and delayed hematoma resolution, providing a molecular link between RIC and immune activation. Finally, chimera studies implicated myeloid CD36 expression in RIC-mediated neurological recovery after ICH. Thus, RIC, a clinically well-tolerated therapy, noninvasively modulates innate immune responses to improve ICH outcomes. Moreover, immunometabolic changes may provide pharmacodynamic blood biomarkers to clinically monitor the therapeutic efficacy of RIC.

Original languageEnglish (US)
Pages (from-to)2636-2654
Number of pages19
JournalThe Journal of experimental medicine
Volume215
Issue number10
DOIs
StatePublished - Oct 1 2018

Fingerprint

Ischemic Postconditioning
AMP-Activated Protein Kinases
Hematoma
Extremities
Cerebral Hemorrhage
Anti-Inflammatory Agents
Parabiosis
Macrophage Activation
Economic Inflation
Myeloid Cells
Innate Immunity

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Remote ischemic post-conditioning promotes hematoma resolution via AMPK-dependent immune regulation. / Vaibhav, Kumar; Braun, Molly; Khan, Mohammad Badruzzaman; Fatima, Sumbul; Saad, Nancy; Shankar, Adarsh; Khan, Zenab T.; Harris, Ruth Babette; Yang, Qiuhua; Huo, Yuqing; Arbab, Ali Syed; Giri, Shailendra; Alleyne, Cargill Herley; Vender, John R; Hess, David C; Baban, Babak; Hoda, MD Nasrul; Dhandapani, Krishnan Michael.

In: The Journal of experimental medicine, Vol. 215, No. 10, 01.10.2018, p. 2636-2654.

Research output: Contribution to journalArticle

Vaibhav, Kumar ; Braun, Molly ; Khan, Mohammad Badruzzaman ; Fatima, Sumbul ; Saad, Nancy ; Shankar, Adarsh ; Khan, Zenab T. ; Harris, Ruth Babette ; Yang, Qiuhua ; Huo, Yuqing ; Arbab, Ali Syed ; Giri, Shailendra ; Alleyne, Cargill Herley ; Vender, John R ; Hess, David C ; Baban, Babak ; Hoda, MD Nasrul ; Dhandapani, Krishnan Michael. / Remote ischemic post-conditioning promotes hematoma resolution via AMPK-dependent immune regulation. In: The Journal of experimental medicine. 2018 ; Vol. 215, No. 10. pp. 2636-2654.
@article{7fae80c15c0540adbbd8d213e4b79fda,
title = "Remote ischemic post-conditioning promotes hematoma resolution via AMPK-dependent immune regulation",
abstract = "Spontaneous intracerebral hemorrhage (ICH) produces the highest acute mortality and worst outcomes of all stroke subtypes. Hematoma volume is an independent determinant of ICH patient outcomes, making clot resolution a primary goal of clinical management. Herein, remote-limb ischemic post-conditioning (RIC), the repetitive inflation-deflation of a blood pressure cuff on a limb, accelerated hematoma resolution and improved neurological outcomes after ICH in mice. Parabiosis studies revealed RIC accelerated clot resolution via a humoral-mediated mechanism. Whereas RIC increased anti-inflammatory macrophage activation, myeloid cell depletion eliminated the beneficial effects of RIC after ICH. Myeloid-specific inactivation of the metabolic regulator, AMPKα1, attenuated RIC-induced anti-inflammatory macrophage polarization and delayed hematoma resolution, providing a molecular link between RIC and immune activation. Finally, chimera studies implicated myeloid CD36 expression in RIC-mediated neurological recovery after ICH. Thus, RIC, a clinically well-tolerated therapy, noninvasively modulates innate immune responses to improve ICH outcomes. Moreover, immunometabolic changes may provide pharmacodynamic blood biomarkers to clinically monitor the therapeutic efficacy of RIC.",
author = "Kumar Vaibhav and Molly Braun and Khan, {Mohammad Badruzzaman} and Sumbul Fatima and Nancy Saad and Adarsh Shankar and Khan, {Zenab T.} and Harris, {Ruth Babette} and Qiuhua Yang and Yuqing Huo and Arbab, {Ali Syed} and Shailendra Giri and Alleyne, {Cargill Herley} and Vender, {John R} and Hess, {David C} and Babak Baban and Hoda, {MD Nasrul} and Dhandapani, {Krishnan Michael}",
year = "2018",
month = "10",
day = "1",
doi = "10.1084/jem.20171905",
language = "English (US)",
volume = "215",
pages = "2636--2654",
journal = "Journal of Experimental Medicine",
issn = "0022-1007",
publisher = "Rockefeller University Press",
number = "10",

}

TY - JOUR

T1 - Remote ischemic post-conditioning promotes hematoma resolution via AMPK-dependent immune regulation

AU - Vaibhav, Kumar

AU - Braun, Molly

AU - Khan, Mohammad Badruzzaman

AU - Fatima, Sumbul

AU - Saad, Nancy

AU - Shankar, Adarsh

AU - Khan, Zenab T.

AU - Harris, Ruth Babette

AU - Yang, Qiuhua

AU - Huo, Yuqing

AU - Arbab, Ali Syed

AU - Giri, Shailendra

AU - Alleyne, Cargill Herley

AU - Vender, John R

AU - Hess, David C

AU - Baban, Babak

AU - Hoda, MD Nasrul

AU - Dhandapani, Krishnan Michael

PY - 2018/10/1

Y1 - 2018/10/1

N2 - Spontaneous intracerebral hemorrhage (ICH) produces the highest acute mortality and worst outcomes of all stroke subtypes. Hematoma volume is an independent determinant of ICH patient outcomes, making clot resolution a primary goal of clinical management. Herein, remote-limb ischemic post-conditioning (RIC), the repetitive inflation-deflation of a blood pressure cuff on a limb, accelerated hematoma resolution and improved neurological outcomes after ICH in mice. Parabiosis studies revealed RIC accelerated clot resolution via a humoral-mediated mechanism. Whereas RIC increased anti-inflammatory macrophage activation, myeloid cell depletion eliminated the beneficial effects of RIC after ICH. Myeloid-specific inactivation of the metabolic regulator, AMPKα1, attenuated RIC-induced anti-inflammatory macrophage polarization and delayed hematoma resolution, providing a molecular link between RIC and immune activation. Finally, chimera studies implicated myeloid CD36 expression in RIC-mediated neurological recovery after ICH. Thus, RIC, a clinically well-tolerated therapy, noninvasively modulates innate immune responses to improve ICH outcomes. Moreover, immunometabolic changes may provide pharmacodynamic blood biomarkers to clinically monitor the therapeutic efficacy of RIC.

AB - Spontaneous intracerebral hemorrhage (ICH) produces the highest acute mortality and worst outcomes of all stroke subtypes. Hematoma volume is an independent determinant of ICH patient outcomes, making clot resolution a primary goal of clinical management. Herein, remote-limb ischemic post-conditioning (RIC), the repetitive inflation-deflation of a blood pressure cuff on a limb, accelerated hematoma resolution and improved neurological outcomes after ICH in mice. Parabiosis studies revealed RIC accelerated clot resolution via a humoral-mediated mechanism. Whereas RIC increased anti-inflammatory macrophage activation, myeloid cell depletion eliminated the beneficial effects of RIC after ICH. Myeloid-specific inactivation of the metabolic regulator, AMPKα1, attenuated RIC-induced anti-inflammatory macrophage polarization and delayed hematoma resolution, providing a molecular link between RIC and immune activation. Finally, chimera studies implicated myeloid CD36 expression in RIC-mediated neurological recovery after ICH. Thus, RIC, a clinically well-tolerated therapy, noninvasively modulates innate immune responses to improve ICH outcomes. Moreover, immunometabolic changes may provide pharmacodynamic blood biomarkers to clinically monitor the therapeutic efficacy of RIC.

UR - http://www.scopus.com/inward/record.url?scp=85054058247&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054058247&partnerID=8YFLogxK

U2 - 10.1084/jem.20171905

DO - 10.1084/jem.20171905

M3 - Article

VL - 215

SP - 2636

EP - 2654

JO - Journal of Experimental Medicine

JF - Journal of Experimental Medicine

SN - 0022-1007

IS - 10

ER -